UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003817
Receipt number R000004602
Scientific Title The comparative study between direct renin inhibitor and angiotensin II receptor antagonist in hypertensive patients with chronic kidney disease
Date of disclosure of the study information 2010/07/01
Last modified on 2012/07/18 14:27:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The comparative study between direct renin inhibitor and angiotensin II receptor antagonist in hypertensive patients with chronic kidney disease

Acronym

The comparative study between direct renin inhibitor and angiotensin II receptor antagonist

Scientific Title

The comparative study between direct renin inhibitor and angiotensin II receptor antagonist in hypertensive patients with chronic kidney disease

Scientific Title:Acronym

The comparative study between direct renin inhibitor and angiotensin II receptor antagonist

Region

Japan


Condition

Condition

chronic kidney disease

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We examine positioning of direct renin inhibitor in the hypertensive treatment of chronic kidney disease

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Blood pressure, Urinary albumin excretion

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Aliskiren fumarate

Interventions/Control_2

Valsartan

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Outpatients with chronic kidney disease at stage 1-4
2) Patients prescribed angiotensin II receptor antagonist over one year
3) Patients prescribed angiotensin II receptor antagonist at most high dose
4) Patients with 150/90 mmHg or less of home blood pressure

Key exclusion criteria

1) Patients with a serious liver damage
2) Patients with a serious renal damage
3) Patients with serum potassium concentration over 5.5 mEq/L

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kazuyoshi Okada

Organization

Itabashi Hospital, Nihon University School of Medicine

Division name

Division of Nephrology, Hypertension and Endocrinology

Zip code


Address

30-1 Oyaguchikamicho, Itabashi-ku, Tokyo

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Itabashi Hospital, Nihon University School of Medicine

Division name

Division of Nephrology, Hypertension and Endocrinology

Zip code


Address


TEL

03-3972-8111

Homepage URL


Email



Sponsor or person

Institute

Division of Nephrology, Hypertension and Endocrinology, Itabashi Hospital, Nihon University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2010 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 06 Month 22 Day

Date of IRB


Anticipated trial start date

2010 Year 10 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 06 Month 24 Day

Last modified on

2012 Year 07 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004602


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name